To Compare the Efficacy, Pharmacokinetics and Safety Between CT-P13 and China Approved Remicade When Co-administered With Methotrexate in Patients With Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis Interventions: Biological: CT-P13; Biological: Remicade Sponsor: Celltrion Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | China Health | Methotrexate | Remicade | Research | Rheumatoid Arthritis | Rheumatology